Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 29, 2016. The report serves as a notification of transactions involving directors, persons discharging managerial responsibilities, or connected persons, in accordance with DTR 3.1.4 R(1)(a) and (c).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a disclosure of share transactions and does not contain financial performance data.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document details specific share transactions executed on April 28, 2016:
- Sir Andrew Witty (Director): Sold 1,025 Ordinary Shares and repurchased 1,017 Ordinary Shares, transferring them into an ISA. Prices were 1488.75p (sale) and 1488.34p (repurchase).
- Lady Caroline Witty (Connected Person): Sold 1,026 Ordinary Shares and repurchased 1,018 Ordinary Shares, transferring them into an ISA. Prices were 1487.65p (sale) and 1487.90p (repurchase).
- Other Connected Persons: Two additional connected persons executed similar sale and repurchase transactions (approx. 1,026-1,028 shares sold, 1,018-1,019 shares repurchased) with prices ranging between 1484.60p and 1487.75p.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the aforementioned share transactions.
Investor Verification Checklist
- Verify the net change in share ownership for Sir Andrew Witty and his connected persons following the April 28, 2016 transactions.
- Confirm the purpose of the transactions (transfer into an Individual Savings Account/ISA) to understand the nature of the liquidity event.
- Review the transaction prices (approx. 1485p-1489p) against the market price on April 28, 2016, to ensure fair execution.
- Note that this filing contains no financial performance data; refer to the company's Form 20-F or quarterly earnings releases for financial metrics.